|
Mr. Sedlack joined Amarin in August 2007 after having spent the last nineteen years in the pharmaceutical and banking industry. Before joining Amarin, Mr. Sedlack was Senior Vice President, Corporate Development for Alba Therapeutics. Prior to this, he was the Global Head of Negotiations, Infectious Diseases for Novartis Pharma AG, based in Basel, Switzerland. Mr. Sedlack was formerly Vice President, Corporate Development with Élan Corporation, plc, where he was responsible for strategic licensing, investments, portfolio management activities, and restructurings. Prior to Élan, he served as Director at the University of Maryland Medical System’s technology licensing office and began his career in banking and finance in 1988 working for ABN AMRO Bank, N.V. and MNC International Bank specializing in international trade finance. | 